- Home
- EVOK vs CYCN Comparison
EVOK vs CYCN Comparison
Compare EVOK & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVOK | CYCN |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 7.6M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVOK | CYCN |
|---|---|---|
| Price | $11.00 | $1.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.8K | ★ 49.9K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,424,652.00 | $2,855,000.00 |
| Revenue This Year | $58.96 | N/A |
| Revenue Next Year | $57.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 67.40 | ★ 1371.65 |
| 52 Week Low | $1.94 | $1.28 |
| 52 Week High | $11.00 | $6.25 |
Technical Indicators
Market Signals| Indicator | EVOK | CYCN |
|---|---|---|
| Relative Strength Index (RSI) | 85.30 | 40.02 |
| Support Level | $10.66 | $1.43 |
| Resistance Level | $10.99 | $1.64 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 100.00 | 6.41 |
Price Performance
Historical ComparisonAbout EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.